---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-044243"
form_type: "8-K"
ticker: "LSH"
cik: "0001996192"
company_name: "Lakeside Holding Ltd"
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T06:03:54.785170+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lakeside Q3 FY2025 revenue falls 15% to $3.8M; net loss of $1.07M vs prior profit

## Summary
- Total revenue $3.80M, down from $4.46M YoY; cross-border freight fell 26%, pharma distribution added $0.50M.
- Net loss attributable to Lakeside $1.07M ($0.14 per share) vs net income $0.01M in Q3 FY2024.
- Nine-month net loss $4.35M ($0.58 per share) vs $0.23M loss a year ago; operating expenses rose to $5.60M from $2.90M.
- Hupan Pharma acquisition closed Nov 2024; contributed $715K to nine-month revenue. Convertible debt up to $4.5M secured March 2025.

## SEC filing metadata
- accession: 0001213900-25-044243
- form_type: 8-K
- ticker: LSH
- cik: 0001996192
- company_name: Lakeside Holding Ltd
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1996192/000121390025044243/0001213900-25-044243-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1996192/000121390025044243/ea0242416-8k_lakeside.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-044243
- JSON: https://secwatch.observer/filing/0001213900-25-044243.json
- Plain text: https://secwatch.observer/filing/0001213900-25-044243.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.